SPA Directory Part 2

Thank-you to everyone who has taken the time to review my last posting.  Below is an update to the directory for companies D-K.

TASE:DPRM	D-Pharm	DP-b99	Acute Ischemic Stroke	http://www.dpharm.com/News.asp?mode=1&type=0&id=133&Year=2011	Yes	http://www.clinicaltrials.gov/ct2/show/NCT00893867?term=D-Pharm&rank=3	Feb-13	Futility analysis
ENDP	Endo Pharma	Urocidin	Bladder ca	http://bioniche.com/news_item.cfm?id=2215		http://www.clinicaltrials.gov/ct2/show/NCT01284205?term=bioniche&rank=5&submit_fld_opt=	n/a	Study withdrawn
EPCT	Epicept	Ceplene	AML	http://investor.epicept.com/releasedetail.cfm?ReleaseID=604432	Pending	n/a	n/a
EPCT	Epicept	Amiket	CIPN	http://investor.epicept.com/releasedetail.cfm?ReleaseID=641427	Pending	n/a	n/a
nil	Essentialis	Diazoxide Choline CR	VHTG's	http://essentialistherapeutics.com/media/Essentialis%20SPA%20Press%20Release%2010-25-10.pdf	Yes	http://www.clinicaltrials.gov/ct2/show/NCT00973271?term=Essentialis&rank=5	Jun-14	My estimate
GALE	Galena	NeuVax	Early stage node+ low-expression HER2 breast cancer	http://www.galenabiopharma.com/pipeline	Yes	http://www.clinicaltrials.gov/ct2/show/NCT01479244?term=NeuVax&rank=1	May-15
GNBT	Generex	AE37	Breast Cancer	http://www.prnewswire.com/news-releases/generex-provides-update-on-company-initiatives-including-the-ae37-breast-cancer-vaccine-program-179098191.html	Pending	n/a	n/a
nil	Helsinn	Netupitant and Palonosetron	CINV	http://www.prnewswire.co.uk/news-releases/fda-agrees-to-special-protocol-assessment-spa-to-evaluate-the-safety-and-efficacy-of-a-fixed-dose-combination-fdc-of-netupitant-and-palonosetron-in-the-prevention-of-cinv-156836265.html	Yes	http://www.clinicaltrials.gov/ct2/show/NCT01376297?term=Netupitant&rank=1	Sep-12
nil	Hyperion Therapeutics	HPN-100	Urea Cycle Disorders	http://files.shareholder.com/downloads/AMDA-1412CE/0x0x585109/0f970e6e-64cd-430e-9796-995fcab86980/HPTX_News_2012_7_7_General_Releases.pdf	Yes	http://www.clinicaltrials.gov/ct2/show/NCT00992459?term=HPN-100&rank=3	Aug-10
LSE:IMM	Immupharma	Lupuzor	SLE	http://www.immupharma.org/lupuzor	Yes	n/a	n/a
nil	Innocoll	Cogenzia	Wound infections	http://innocollinc.com/cogenzia.html	Yes	n/a	n/a
INSV	InSite Vision	Dexasite/Azasite	Blepharitis	http://phx.corporate-ir.net/phoenix.zhtml?c=86061&p=irol-newsArticle&ID=1631034&highlight=	Yes	http://www.clinicaltrials.gov/ct2/show/NCT01408082?term=Insite+vision&rank=5&submit_fld_opt=	Dec-12
ISA.TO	Isotechnika Pharma	Voclosporin	Kidney Transplant	http://www.isotechnika.com/dnn/LinkClick.aspx?fileticket=UrRyyein3D8%3D&tabid=92&mid=671	Yes	http://www.clinicaltrials.gov/ct2/show/NCT01586845?term=voclosporin&rank=1	Mar-15
nil	ISTA Pharma/B&L	Remura	Dry Eye Syndrome	http://www.prnewswire.com/news-releases/ista-pharmaceuticals-initiates-phase-3-clinical-program-for-remura-in-dry-eye-disease-103037129.html	Yes	http://www.clinicaltrials.gov/ct2/show/NCT01212471?term=ISTA+bromfenac&rank=4	Dec-11
KERX	Keryx	Zerenex	Hyperphosphatemia in ESRD	http://www.keryx.com/page.cfm?hmid=20&smid=0&pg=4b	Yes	http://www.clinicaltrials.gov/ct2/show/NCT01191255?term=zerenex&rank=2	Dec-12